Molecule Details
| InChIKey | HMZQULPVMKITSP-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-[5-(7-Aza-bicyclo[2.2.1]hept-2-yl)-2-fluoro-pyridin-3-yl]-benzonitrile |
| Canonical SMILES | N#Cc1ccc(-c2cc(C3CC4CCC3N4)cnc2F)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.72 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB14029 |
|---|---|
| Drug Name | Furafylline |
| CAS Number | 80288-49-9 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Furafylline is a derivative of methylxanthine derivative. It was developed on the context of asthma as a long-acting alternative for [theophylline]. |
Categories: Alkaloids Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strong) Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Purines Purinones Xanthine derivatives
Cross-references: BindingDB: 50171007 CHEMBL372638 ChemSpider: 23262468 Wikipedia: Furafylline
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P05177 | CYP1A2 | Cytochrome P450 1A2 | inhibitor | enzymes |